Sign In
Buy SHRMF
$0.403
+0 (+0%)
At Close: May 12, 2022
/R E P E A T -- Braxia Scientific Announces Symbol Change on OTC markets to "BRAXF"/
07:05am, Friday, 21'st May 2021
TORONTO, May 20, 2021 /PRNewswire/ - Braxia Scientific Corp. (the "Company"), (CSE: BRAX) (OTC: SHRMF) (FWB: 496), a research driven clinical platform developing and providing novel ketamine treatmen
Braxia Scientific Announces Symbol Change on OTC Markets to "BRAXF"
08:18pm, Thursday, 20'th May 2021
TORONTO, May 20, 2021 /PRNewswire/ - Braxia Scientific Corp. (the "Company"), (CSE: BRAX) (OTC: SHRMF) (FWB: 496), a research driven clinical platform developing and providing novel ketamine treatmen
Braxia Scientific Corp (CSE:BRAX) (OTCMKTS:SHRMF) (FRA:4960) has launched the Braxia Institute, its training Centre of Excellence focused on advancing psychiatric clinical practice and health services
Over 200 physicians and healthcare providers from Canada, U.S., and Asia to attend Braxia's Symposium on rapid acting anti-depressants (RAAD) which include ketamine, esketamine and psychedelic therapi
NEW YORK, May 19, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Braxia Scientific Corp. f/k/a Champignon Brands Inc. ("Champignon
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Braxia Scientific Corp. f/k/a Champignon Brands Inc. (“Champignon”) (OTC:
New York, New York--(Newsfile Corp. - May 14, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Braxia Scientific Corp. f/k/a Champignon Brands I
Braxia Scientific opens first ketamine therapy clinic in Quebec
09:17am, Thursday, 13'th May 2021
Braxia Scientific Corp (CSE:BRAX) (OTCMKTS:SHRMF) (FRA:4960) announced it had opened its first ketamine therapy clinic in Quebec – its fourth centre in Canada. The clinic, operating under Braxia's
In Quebec, ~20% of the population, or 1 in 5 people, experience mental illness during their lifetime; Covid-19 has further exacerbated the number of adults experiencing symptoms of major depression Th
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Champignon Brands Inc. - SHRMF
05:02am, Thursday, 13'th May 2021
NEW YORK, May 13, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Champignon Brands Inc. ("Champignon" or the "Company") (OTCMKTS: SHRMF). Such investors are a
Los Angeles, California--(Newsfile Corp. - May 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Champignon Brands Inc
Braxia Scientific rebrands its psychedelic research and treatment clinics for mental disorders to Braxia Health
08:01am, Monday, 10'th May 2021
Braxia Scientific Corp (CSE:BRAX) (FRA:496) (OTCQB:SHRMF) has announced that it is rebranding its growing network of psychedelic research and treatment clinics for mental health disorders to Braxia He
Braxia Scientific enters a new chapter as it commences trading under its new ticker "CSE: BRAX" and rebrands its growing network of leading clinics to Braxia Health, which includes the Canadian Rapid
NEW YORK, May 5, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Champignon Brands Inc. (OTC: SHRMF) between March 27, 2020 and Feb
Braxia Scientific is making a scientific case for psychedelic medicine
04:54pm, Wednesday, 05'th May 2021
First mover in the red-hot psychedelic medicine field Pioneering the use of psychedelics to treat mental health and addiction disorders Strong portfolio of research into psychedelics complements ongo
